Legal status · Canada
Is SHLP2 legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. SHLP2 is not an approved medicine in Canada; its classification is "Not a medicine; endogenous signalling molecule". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
SHLP2 in Canada at a glance
| Classification | Not a medicine; endogenous signalling molecule |
|---|---|
| Note | Endogenous peptide. No approved product. |
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 2 of 6 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the SHLP2 profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing SHLP2 is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What SHLP2 is
A mitochondrial-derived peptide with an identified receptor, a mouse obesity result and a human genetic association with protection against Parkinson's disease. It has never been administered to a person, and no trial is registered.
In 2016 a search of the same stretch of mitochondrial 16S ribosomal RNA that encodes humanin turned up six more short open reading frames. Those became SHLP1 through SHLP6, the small humanin-like peptides.
Mechanism: Encoded in the mitochondrial genome, in the 16S rRNA region, and released to act as a signalling peptide. The identified receptor is CXCR7, an atypical chemokine receptor.
Regulatory history: Not approved, not in development as a drug in any public filing, and with no investigational new drug programme located. It is an endogenous peptide that people can measure in plasma, not a product.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for SHLP2 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
SHLP2 in other countries
United States
Not approvedNot a medicine; endogenous signalling molecule
Is SHLP2 legal in the United States?United Kingdom
Not approvedNot a medicine; endogenous signalling molecule
Is SHLP2 legal in the United Kingdom?Australia
Not approvedNot a medicine; endogenous signalling molecule
Is SHLP2 legal in Australia?Frequently asked questions
Is SHLP2 legal in Canada?
No. SHLP2 is not an approved medicine in Canada; its classification is "Not a medicine; endogenous signalling molecule". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile. Note: Endogenous peptide. No approved product.
Can I buy SHLP2 in Canada?
No approved product exists to buy. In Canada SHLP2 is classified as "Not a medicine; endogenous signalling molecule", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Endogenous peptide. No approved product.
Is SHLP2 Health Canada approved?
No. In Canada SHLP2 is classified as "Not a medicine; endogenous signalling molecule", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Not approved, not in development as a drug in any public filing, and with no investigational new drug programme located. It is an endogenous peptide that people can measure in plasma, not a product.. On the evidence, 2 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for SHLP2 live on its compound profile.
SHLP2 profileThis page is general information about the regulatory status of SHLP2 in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.